Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019621 (
Langerhans cell histiocytosis
)
3,250
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
High resolution computed tomography (TDM-HR) is now the technique of choice in the diagnosis and management of diffuse infiltrative lung disease (PID). After a brief review of the technique the authors describe the normal appearance; anatomical observations and the in vivo findings have shown that TDM-HR allow for the exploration of details of structure down to the second pulmonary lobule. Thus, through the alterations that are transmitted in the lobular area, and from its contents and its limits, PID has led to the elaboration of a new semeiology. The authors review the basic computed tomographic images and correlate these in each case with the histological evidence. The spatial distribution and the time sequence of the elementary images are the two other terms in the diagnostic equation of PID. The spatial distribution of several elementary images presents in TDM-HR a superior aetiological pointer to that which is furnished by thoracic radiographs; and the time sequence may furnish a useful indication as to the progress of the treated disease. Sarcoidosis,
histiocytosis X
, idiopathic interstitial fibrosis and lymphangitis
carcinomatosis
would serve as examples. Nevertheless, the authors point out that it would be dangerous during the period of evaluation to prematurely extend to all cases of PID conclusions which are only possible to make at present in a restricted number of disorders.
...
PMID:[Diffuse infiltrative lung diseases: histological support of elementary lesions observed on tomodensitometry]. 150 84
Scintigraphic evaluation of 67Ga citrate was made in 102 patients with diffuse pulmonary lesions (DPL) of various genesis. There was respiratory sarcoidosis in 40 patients, exogenous allergic alveolitis in 47, idiopathic fibrosing alveolitis in 3,
histiocytosis X
in 6, and
carcinomatosis
in 6. Radionuclide findings indicated that the radioagent accumulated in intrathoracic lymph nodes of the mediastinum and partially in the lung tissue in 75.5% of cases at the acute stage of the disease, negative results were in 24.5%, as explained by the fact that the studies were conducted at remission or in the presence of pneumosclerosis. Reexaminations of DPL patients using 67Ga citrate may yield objective information on the treatment performed and, if the latter fails, correct it.
...
PMID:[Scintigraphic evaluation of 67GA citrate in the comprehensive study of diffuse pulmonary lesions]. 901 78
Erdheim-Chester disease (ECD) is a rare proliferative non-
Langerhans cell histiocytosis
of multiple organs with unknown etiology. Around 20% of ECD cases are reported to be associated with lung involvement and there are very few cases manifested solely by nonspecific respiratory symptoms. A 50-year-old woman presented with dry cough and dyspnea for 2 weeks. Chest computed tomography (CT) revealed diffuse interlobular septal and fissural thickening with perilymphatic and subpleural nodular opacities, suggesting pulmonary lymphangitic spread of metastatic carcinoma. Bone scintigraphy and positron emission tomography/CT showed multiple skeletal and lymph node involvement. The patient underwent surgical lung biopsy and the pathologic feature was consistent with ECD. We describe this case to emphasize that ECD should be included in the differential diagnosis of cases suspected to have lymphangitic lung
carcinomatosis
. Moreover, the findings of positron emission tomography/CT scan, which showed hot uptakes in the affected areas, are also described.
...
PMID:Erdheim-Chester disease with lung involvement mimicking pulmonary lymphangitic carcinomatosis. 1936 81
Bilateral lung parenchymal involvement is seen in infective as well as noninfective conditions, appearing as focal or diffuse lung disease. PET/CT with FDG helps in characterization (increased glucose utilization is seen by both inflammatory and neoplastic cells). In this article, we describe the spectrum of patterns of FDG uptake and associated CT changes involving bilateral lung parenchyma. Benign conditions described are aspiration pneumonia; pulmonary toxicity by bleomycin; infections, namely, sarcoidosis, miliary pulmonary tuberculosis, and pulmonary nocardiosis; and inflammatory conditions such as pulmonary
Langerhans cell histiocytosis
and pulmonary alveolar proteinosis. Neoplastic conditions described are bilateral pulmonary metastases and lymphangitic
carcinomatosis
.
...
PMID:Spectrum of 18F-FDG Uptake in Bilateral Lung Parenchymal Diseases on PET/CT. 3152 73